Optimized parvovirus H-1 production
US-12404498-B2 · Sep 2, 2025 · US
This page is not indexed by search engines while we improve data quality.
Leuchs Barbara patents
Leuchs Barbara is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Leuchs Barbara |
| Total patents | 26 |
| First publication | Jan 12, 2016 |
| Latest publication | Sep 2, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Method for further upscaling the large-scale production of the oncolytic h-1 protoparvovirus (h-1pv) using a carrier-based production process combined with an optimized cell culture medium
US-2025043251-A1 · Feb 6, 2025 · US
H-1 PV EXPRESSING RNAi EFFECTORS
US-2024182907-A1 · Jun 6, 2024 · US
Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor
US-11964015-B2 · Apr 23, 2024 · US
Optimized method for large scale production of parvovirus h-1 in an essentially serum-free medium
US-2022290108-A1 · Sep 15, 2022 · US
Parvovirus formulation for treating tumors
US-11324788-B2 · May 10, 2022 · US
Scalable process for oncolytic rat parvovirus H-1 production and purification based on isoelectric point-based elimination of empty particles
US-11193112-B2 · Dec 7, 2021 · US
Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor
US-2021228714-A1 · Jul 29, 2021 · US
Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor
US-11027013-B2 · Jun 8, 2021 · US
H-1 pv expressing rnai effectors targeting cdk9
US-2020385738-A1 · Dec 10, 2020 · US
Recent patents
Latest publications not already listed above.
Parvovirus formulation for treating tumors
US-2020215134-A1 · Jul 9, 2020 · US
Parvovirus formulation for treating tumors
US-10624935-B2 · Apr 21, 2020 · US
Use of parvovirus for eliminating cancer stem cells (CSCs)
US-10525091-B2 · Jan 7, 2020 · US
Scalable process for oncolytic rat parvovirus h-1 production and purification based on isoelectric point-based elimination of empty particles
US-2019256823-A1 · Aug 22, 2019 · US
Optimized method for large scale production of parvovirus h-1 in an essentially serum-free medium
US-2019203184-A1 · Jul 4, 2019 · US
Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor
US-2019117768-A1 · Apr 25, 2019 · US
Method for large scale production and purification of parvovirus
US-10266810-B2 · Apr 23, 2019 · US
Modified parvovirus useful for gene silencing
US-10227609-B2 · Mar 12, 2019 · US
Method for large scale production and purification of parvovirus
US-2018187166-A1 · Jul 5, 2018 · US
Parvovirus formulation for treating tumors
US-2018110813-A1 · Apr 26, 2018 · US
Adenovirus derived helper virus for enhancing recombinant parvovirus production
US-9803219-B2 · Oct 31, 2017 · US
USE OF PARVOVIRUS FOR ELIMINATING CANCER STEM CELLS (CSCs)
US-2017266244-A1 · Sep 21, 2017 · US
Use of parvovirus for eliminating cancer stem cells (CSCs)
US-9700588-B2 · Jul 11, 2017 · US
Adenovirus derived helper virus for enhancing recombinant parvovirus production
US-2017073704-A9 · Mar 16, 2017 · US
Oncolytic virotherapy for the therapy of ewing'S sarcoma
US-9333225-B2 · May 10, 2016 · US
Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsid
US-9234183-B2 · Jan 12, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Deutsches Krebsforsch | 25 |
| Univ Heidelberg Ruprecht Karls | 9 |
| Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | 3 |
| Ruprecht-Karls-Universitaet Heidelberg | 2 |
| Rommelaere Jean | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 20 |
| A61K35/768 | 13 |
| C12N7/00 | 10 |
| C12N2750/14351 | 10 |
| C12N2750/14332 | 9 |